This study aims to provide a comprehensive review of the Kirsten rat sarcoma viral oncogene (KRAS)-related treatment for patients with PC, especially pancreatic ductal adenocarcinoma (PDAC). This evidence concerns the gene KRAS and pachyonychia congenita.